EA202091237A1 - Новые полиморфные формы тримебутина малеата, способ получения и применения - Google Patents
Новые полиморфные формы тримебутина малеата, способ получения и примененияInfo
- Publication number
- EA202091237A1 EA202091237A1 EA202091237A EA202091237A EA202091237A1 EA 202091237 A1 EA202091237 A1 EA 202091237A1 EA 202091237 A EA202091237 A EA 202091237A EA 202091237 A EA202091237 A EA 202091237A EA 202091237 A1 EA202091237 A1 EA 202091237A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- polymorphic forms
- obtaining
- application
- new polymorphic
- trimebutin maleate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/20—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C219/22—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/18—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2017140269A RU2706166C2 (ru) | 2017-11-20 | 2017-11-20 | Новые полиморфные формы тримебутина малеата, способ получения и применения |
PCT/RU2018/000729 WO2019098883A1 (ru) | 2017-11-20 | 2018-11-08 | Полиморфные формы тримебутина малеата и способ применения |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202091237A1 true EA202091237A1 (ru) | 2020-08-17 |
Family
ID=66540370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202091237A EA202091237A1 (ru) | 2017-11-20 | 2018-11-08 | Новые полиморфные формы тримебутина малеата, способ получения и применения |
Country Status (7)
Country | Link |
---|---|
KR (1) | KR102509190B1 (ko) |
CN (1) | CN111432811B (ko) |
BR (1) | BR112020010135A2 (ko) |
EA (1) | EA202091237A1 (ko) |
RU (1) | RU2706166C2 (ko) |
UA (1) | UA124755C2 (ko) |
WO (1) | WO2019098883A1 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2752086C1 (ru) * | 2020-04-27 | 2021-07-22 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Новое соединение [2-(диметиламино)-2-фенилбутил]-3,4,5-триметоксибензоата 4-метил-2н-хромен-2-он-7-илсульфат и его применение |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2131804B1 (ko) * | 1971-03-12 | 1974-03-22 | Jouveinal Sa | |
FR2752162B1 (fr) * | 1996-08-07 | 1998-11-06 | Jouveinal Lab | Comprime de maleate de trimebutine pellicule |
CN102188389B (zh) * | 2010-03-18 | 2014-04-02 | 杭州赛利药物研究所有限公司 | 马来酸曲美布汀干混悬剂及其制备方法 |
KR101220829B1 (ko) * | 2010-07-16 | 2013-01-10 | 안국약품 주식회사 | 트리메부틴 함유 서방성 정제 |
EP2481403A1 (en) * | 2011-02-01 | 2012-08-01 | Deva Holding Anonim Sirketi | Pharmaceutical combination of otilonium and trimebutine |
MX2014010910A (es) * | 2012-03-12 | 2015-03-09 | Gicare Pharma Inc | Sales novedosas de trimebutina basadas en sulfonato. |
-
2017
- 2017-11-20 RU RU2017140269A patent/RU2706166C2/ru active
-
2018
- 2018-11-08 EA EA202091237A patent/EA202091237A1/ru unknown
- 2018-11-08 BR BR112020010135-4A patent/BR112020010135A2/pt unknown
- 2018-11-08 WO PCT/RU2018/000729 patent/WO2019098883A1/ru active Application Filing
- 2018-11-08 UA UAA202003442A patent/UA124755C2/uk unknown
- 2018-11-08 CN CN201880074646.0A patent/CN111432811B/zh active Active
- 2018-11-08 KR KR1020207016962A patent/KR102509190B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
RU2017140269A3 (ko) | 2019-05-20 |
KR102509190B1 (ko) | 2023-03-14 |
WO2019098883A1 (ru) | 2019-05-23 |
UA124755C2 (uk) | 2021-11-10 |
RU2017140269A (ru) | 2019-05-20 |
KR20200110308A (ko) | 2020-09-23 |
BR112020010135A2 (pt) | 2021-03-23 |
CN111432811B (zh) | 2023-06-23 |
CN111432811A (zh) | 2020-07-17 |
RU2706166C2 (ru) | 2019-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201691974A1 (ru) | Антитела против ox40 и способы их применения | |
EA201790984A1 (ru) | Анти-cd79b антитела и способы их применения | |
EA201890725A1 (ru) | Агонисты фарнезоидного х-рецептора и их применение | |
EA201792590A1 (ru) | КОНЪЮГАТ АНТИТЕЛА ПРОТИВ ErbB2 И ЛЕКАРСТВЕННОГО СРЕДСТВА И ЕГО КОМПОЗИЦИЯ, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО ПРИМЕНЕНИЕ | |
EA201691610A8 (ru) | Анти-jagged1 антитела и способы применения | |
EA201691582A1 (ru) | Новые фармацевтические препараты | |
EA201691134A1 (ru) | Новые ингибиторы глутаминазы | |
EA201790529A1 (ru) | Новые антитела против mfi2 и способы их применения | |
EA201691541A1 (ru) | Новые анти-baff антитела | |
EA201790650A1 (ru) | Лекарственная форма и способы применения абиратерона ацетата | |
CR20190387A (es) | Anticuerpos contra triptasa, composiciones de estos y usos de estos | |
EA201492282A1 (ru) | Антагонистические антигенсвязывающие белки к двум рецепторам и их применение | |
EA202091337A1 (ru) | Ингибиторы гистонацетилтрансфераз семейства myst | |
EA201791992A1 (ru) | Ингибиторы грелин-o-ацилтрансферазы | |
EA201792000A1 (ru) | Ингибиторы грелин-o-ацилтрансферазы | |
DK3744316T3 (da) | Oftalmisk farmaceutisk sammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
EA201792262A1 (ru) | Пироглутамат вортиоксетина | |
EA202091259A1 (ru) | Способ получения опикапона и его интермедиатов | |
EA201790445A1 (ru) | Производные индолинона и их применение | |
EA201890364A1 (ru) | СОЕДИНЕНИЯ, ПРИГОДНЫЕ ДЛЯ ИНГИБИРОВАНИЯ ROR-ГАММА-t | |
EA201992883A1 (ru) | АНТИТЕЛА К TrkB | |
EA202091567A1 (ru) | Химерные белки мти | |
EA201790699A1 (ru) | Стабилизированные производные адреномедуллина и их применение | |
EA201790893A1 (ru) | Способы лечения офтальмологических расстройств | |
EA201691493A1 (ru) | Замещенные n-арилпиридиноны |